Farxiga and Jardiance are part of a new class of diabetes drugs that also includes Invokana. These diabetes drugs, called SGLT2 Inhibitors, are already causing a plethora of problems with the diabetics who use them.
As a result of the risks associated with side effects of Invokana, Farxiga, Jardiance and other SGLT2 inhibitors, the FDA is requiring a revision to the warning labels, adding information about the risk of ketoacidosis, as well as urinary tract infections and kidney infections that could become life-threatening cases of urosepsis, a life-threatening blood infection.
If you or a loved one has taken Invokana, Farxiga, or Jardiance and been hospitalized with ketoacidosis, urosepsis, kidney damage and/or renal failure, contact us online or call 1-866-252-3535 for a free consultation.
Share this page...